201 related articles for article (PubMed ID: 26154425)
1. Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy.
Ahmed M; Kumar G; Navarro G; Wang Y; Gourevitch S; Moussa MH; Rozenblum N; Levchenko T; Galun E; Torchilin VP; Goldberg SN
PLoS One; 2015; 10(7):e0128910. PubMed ID: 26154425
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Thermal Ablation: Effect of Device and Heating Parameters on Local Tissue Reactions and Distant Tumor Growth.
Velez E; Goldberg SN; Kumar G; Wang Y; Gourevitch S; Sosna J; Moon T; Brace CL; Ahmed M
Radiology; 2016 Dec; 281(3):782-792. PubMed ID: 27409564
[TBL] [Abstract][Full Text] [Related]
3. Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition.
Kumar G; Goldberg SN; Wang Y; Velez E; Gourevitch S; Galun E; Ahmed M
Eur Radiol; 2017 Mar; 27(3):1238-1247. PubMed ID: 27287478
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation (RFA)-induced systemic tumor growth can be reduced by suppression of resultant heat shock proteins.
Ahmed M; Kumar G; Gourevitch S; Levchenko T; Galun E; Torchilin V; Goldberg SN
Int J Hyperthermia; 2018 Nov; 34(7):934-942. PubMed ID: 29631466
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Radiofrequency Ablation-induced Stimulation of Distant Tumor Growth Is Suppressed by c-Met Inhibition.
Ahmed M; Kumar G; Moussa M; Wang Y; Rozenblum N; Galun E; Goldberg SN
Radiology; 2016 Apr; 279(1):103-17. PubMed ID: 26418615
[TBL] [Abstract][Full Text] [Related]
6. Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation.
Kumar G; Goldberg SN; Gourevitch S; Levchenko T; Torchilin V; Galun E; Ahmed M
Radiology; 2018 Feb; 286(2):524-536. PubMed ID: 28880787
[TBL] [Abstract][Full Text] [Related]
7. Incomplete thermal ablation of tumors promotes increased tumorigenesis.
Markezana A; Goldberg SN; Kumar G; Zorde-Khvalevsky E; Gourevtich S; Rozenblum N; Galun E; Ahmed M
Int J Hyperthermia; 2021; 38(1):263-272. PubMed ID: 33612046
[TBL] [Abstract][Full Text] [Related]
8. Effect of thermal dose on heat shock protein expression after radio-frequency ablation with and without adjuvant nanoparticle chemotherapies.
Moussa M; Goldberg SN; Kumar G; Levchenko T; Torchilin V; Ahmed M
Int J Hyperthermia; 2016 Dec; 32(8):829-841. PubMed ID: 27600101
[TBL] [Abstract][Full Text] [Related]
9. Thermal Ablation Induces Transitory Metastatic Growth by Means of the STAT3/c-Met Molecular Pathway in an Intrahepatic Colorectal Cancer Mouse Model.
Liao H; Ahmed M; Markezana A; Zeng G; Stechele M; Galun E; Goldberg SN
Radiology; 2020 Feb; 294(2):464-472. PubMed ID: 31845846
[TBL] [Abstract][Full Text] [Related]
10. Mesna preserves hepatocyte regenerating capacity following liver radiofrequency ablation under Pringle maneuver.
Ypsilantis P; Lambropoulou M; Anagnostopoulos C; Tentes I; Tsigalou C; Pitiakoudis M; Kortsaris A; Papadopoulos N; Simopoulos C
J Surg Res; 2011 Jul; 169(1):44-50. PubMed ID: 20080247
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.
Erös de Bethlenfalva-Hora C; Mertens JC; Piguet AC; Kettenbach J; Schmitt J; Terracciano L; Weimann R; Dufour JF; Geier A
Clin Sci (Lond); 2014 Feb; 126(3):243-52. PubMed ID: 23822114
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.
Jiang T; Zhang X; Ding J; Duan B; Lu S
Int J Clin Exp Pathol; 2015; 8(11):13945-56. PubMed ID: 26823706
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib suppresses the rapid progress of hepatocellular carcinoma after insufficient radiofrequency ablation therapy: an experiment in vivo.
Xu M; Xie XH; Xie XY; Xu ZF; Liu GJ; Zheng YL; Huang GL; Wang W; Zheng SG; Lü MD
Acta Radiol; 2013 Mar; 54(2):199-204. PubMed ID: 23171528
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation-induced upregulation of hypoxia-inducible factor-1α can be suppressed with adjuvant bortezomib or liposomal chemotherapy.
Moussa M; Goldberg SN; Kumar G; Sawant RR; Levchenko T; Torchilin V; Ahmed M
J Vasc Interv Radiol; 2014 Dec; 25(12):1972-82. PubMed ID: 25439675
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation.
Ahmed M; Monsky WE; Girnun G; Lukyanov A; D'Ippolito G; Kruskal JB; Stuart KE; Torchilin VP; Goldberg SN
Cancer Res; 2003 Oct; 63(19):6327-33. PubMed ID: 14559820
[TBL] [Abstract][Full Text] [Related]
16. Nanodrug-enhanced radiofrequency tumor ablation: effect of micellar or liposomal carrier on drug delivery and treatment efficacy.
Moussa M; Goldberg SN; Kumar G; Sawant RR; Levchenko T; Torchilin VP; Ahmed M
PLoS One; 2014; 9(8):e102727. PubMed ID: 25133740
[TBL] [Abstract][Full Text] [Related]
17. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
[TBL] [Abstract][Full Text] [Related]
18. In vivo detection of distal tumor glycolytic flux stimulated by hepatic ablation in a breast cancer model using hyperpolarized
Goodwin JS; Tsai LL; Mwin D; Coutinho de Souza P; Dialani S; Moon JT; Zhang Z; Grant AK; Ahmed M
Magn Reson Imaging; 2021 Jul; 80():90-97. PubMed ID: 33901585
[TBL] [Abstract][Full Text] [Related]
19. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.
Hines-Peralta A; Sukhatme V; Regan M; Signoretti S; Liu ZJ; Goldberg SN
Radiology; 2006 Jul; 240(1):82-9. PubMed ID: 16720872
[TBL] [Abstract][Full Text] [Related]
20. Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation.
Behm B; Di Fazio P; Michl P; Neureiter D; Kemmerling R; Hahn EG; Strobel D; Gress T; Schuppan D; Wissniowski TT
Gut; 2016 Jan; 65(1):134-43. PubMed ID: 25524262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
